Discusses Financing and Robin Trial Strategy for Neoadjuvant Immunotherapy in MSS Colon Cancer July 13, 2026 8:30 AM ...
A new study from Virginia Tech found that scientists' credibility often hinges on their perceived motivations. "Our study ...
There are several psychological reasons why some people reject scientific consensus. How distant one feels psychologically ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Bids on “Gus” will start at $19 million, a steep price for public institutions. Specimens in private collections can be harder for researchers to examine, and they’re practically impossible to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results